Works matching AU Cha, Bong‐Soo

Results: 76
    1
    2
    3

    Efficacy and safety of lobeglitazone versus sitagliptin as an add‐on to metformin in patients with type 2 diabetes with two or more components of metabolic syndrome over 24 weeks.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 10, p. 1869, doi. 10.1111/dom.14085
    By:
    • Kim, Sin Gon;
    • Kim, Kyoung Jin;
    • Yoon, Kun Ho;
    • Chun, Sung Wan;
    • Park, Kyong Soo;
    • Choi, Kyung Mook;
    • Lim, Soo;
    • Mok, Ji‐Oh;
    • Lee, Hyoung Woo;
    • Seo, Ji A.;
    • Cha, Bong‐Soo;
    • Kim, Mi Kyung;
    • Shon, Ho Sang;
    • Choi, Dong Seop;
    • Kim, Doo Man
    Publication type:
    Article
    4

    Cover Image, Volume 21, Issue 4.

    Published in:
    Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. i, doi. 10.1111/dom.13688
    By:
    • Kim, Jin Hee;
    • Lee, Minyoung;
    • Kim, Soo Hyun;
    • Kim, So Ra;
    • Lee, Byung‐Wan;
    • Kang, Eun Seok;
    • Cha, Bong‐Soo;
    • Cho, Jin Won;
    • Lee, Yong‐ho
    Publication type:
    Article
    5
    6
    7

    Efficacy and safety of ipragliflozin as an add‐on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2018, v. 20, n. 10, p. 2408, doi. 10.1111/dom.13394
    By:
    • Han, Kyung‐ah;
    • Chon, Suk;
    • Chung, Choon Hee;
    • Lim, Soo;
    • Lee, Kwan‐woo;
    • Baik, Seihyun;
    • Jung, Chang Hee;
    • Kim, Dong‐sun;
    • Park, Kyong Soo;
    • Yoon, Kun‐ho;
    • Lee, In‐kyu;
    • Cha, Bong‐soo;
    • Sakatani, Taishi;
    • Park, Sumi;
    • Lee, Moon‐kyu
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus.

    Published in:
    Clinical Endocrinology, 2007, v. 66, n. 2, p. 282, doi. 10.1111/j.1365-2265.2006.02723.x
    By:
    • Kim, Hyeong Jin;
    • Kang, Eun Seok;
    • Kim, Dae Jung;
    • Kim, So Hun;
    • Ahn, Chul Woo;
    • Cha, Bong Soo;
    • Nam, Moonsuk;
    • Chung, Choon Hee;
    • Lee, Kwan Woo;
    • Nam, Chung Mo;
    • Lee, Hyun Chul
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38

    SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.

    Published in:
    Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15983-6
    By:
    • Kim, So Ra;
    • Lee, Sang-Guk;
    • Kim, Soo Hyun;
    • Kim, Jin Hee;
    • Choi, Eunhye;
    • Cho, Wonhee;
    • Rim, John Hoon;
    • Hwang, Inhwa;
    • Lee, Chan Joo;
    • Lee, Minyoung;
    • Oh, Chang-Myung;
    • Jeon, Justin Y.;
    • Gee, Heon Yung;
    • Kim, Jeong-Ho;
    • Lee, Byung-Wan;
    • Kang, Eun Seok;
    • Cha, Bong-Soo;
    • Lee, Myung-Shik;
    • Yu, Je-Wook;
    • Cho, Jin Won
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50